
Zepp Health Corporation: shareholders and insiders
Price
$2.31
November 20, 2026Market cap $37M
What Ploutos Investor adds for Zepp Health
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from 2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Jun 26, 2026 to Sep 25, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$87.5K
2 people
From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
- Sep 24, 2026Pengtao YuChief Industrial DesignerKind
- Sep 23, 2026Pengtao YuChief Industrial DesignerKind
- Jun 26, 2026Meihui FANChief Technology OfficerKind
- Jun 26, 2026Cheng DengChief Financial OfficerKind
- Jun 26, 2026Cheng DengChief Financial OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Pengtao YuChief Industrial Designer | 4,251 | $4.09 | $17.4K | Form 4 | |
| Sep 23, 2026 | Pengtao YuChief Industrial Designer | 5,749 | $4.30 | $24.7K | Form 4 | |
| Jun 26, 2026 | Meihui FANChief Technology Officer | 520.0K | – | – | Form 4 | |
| Jun 26, 2026 | Cheng DengChief Financial Officer | 22.9K | – | – | Form 4 | |
| Jun 26, 2026 | Cheng DengChief Financial Officer | 9,836 | $4.61 | $45.3K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Morgan Stanleywith 1 more personClass A Ordinary Shares / American Depositary ReceiptsShare of class8.80%
- FIL Limitedwith 2 more personsCLASS A COMMON STOCKShare of class5.60%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Morgan Stanleywith 1 more personClass A Ordinary Shares / American Depositary Receipts | 8.80% | 11.87M | Aug 13, 20263 filings since Jun 26, 2026 | 13G/A | |
| FIL Limitedwith 2 more personsCLASS A COMMON STOCK | 5.60% | 7.52M | Nov 5, 20266 filings since May 7, 2025 | 13G/A |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
No well-known manager
None of the managers we track held Zepp Health shares in their latest 13F.
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short sales in daily trading
How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.
In the last 14 sessions, 47.3% of the shares in the reported trades were short sales, against 42.1% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 47.3%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 42.1%
- Change
- +5.2 pts
- Short sales a dayon average, of 29.2K shares
- 13.8K
- More than atof 3,674 US-listed companies, same days
- 39%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 36.2%
- Oct 15, 2026: Short sales 39.4%
- Oct 16, 2026: Short sales 50.2%
- Oct 19, 2026: Short sales 56%
- Oct 20, 2026: Short sales 45.1%
- Oct 21, 2026: Short sales 35.1%
- Oct 22, 2026: Short sales 43.7%
- Oct 23, 2026: Short sales 47.3%
- Oct 26, 2026: Short sales 37.9%
- Oct 27, 2026: Short sales 36.9%
- Oct 28, 2026: Short sales 25.9%
- Oct 29, 2026: Short sales 43.2%
- Oct 30, 2026: Short sales 37.4%
- Nov 2, 2026: Short sales 44.9%
- Nov 3, 2026: Short sales 52.7%
- Nov 4, 2026: Short sales 40.8%
- Nov 5, 2026: Short sales 37.4%
- Nov 6, 2026: Short sales 41%
- Nov 9, 2026: Short sales 53%
- Nov 10, 2026: Short sales 58.6%
- Nov 11, 2026: Short sales 48.9%
- Nov 12, 2026: Short sales 48.4%
- Nov 13, 2026: Short sales 46.4%
- Nov 16, 2026: Short sales 51.9%
- Nov 17, 2026: Short sales 29.9%
- Nov 18, 2026: Short sales 58.7%
- Nov 19, 2026: Short sales 21.3%
- Nov 20, 2026: Short sales 60%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Meihui FANChief Technology OfficerDirectly952.0K
- Cheng DengChief Financial OfficerDirectly114.5K
- Pengtao YuChief Industrial DesignerDirectly98.5K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Meihui FANChief Technology Officer | 952.0K | – | Jun 26, 2026 | Form 4 |
| Cheng DengChief Financial Officer | 114.5K | – | Jun 26, 2026 | Form 4 |
| Pengtao YuChief Industrial Designer | 98.5K | – | Sep 24, 2026 | Form 4 |
A lower bound: it counts only the 3 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 33
- Q4 2025: Managers 38
- Q1 2026: Managers 32
- Q2 2026: Managers 28
Institutional investors by quarter
The fund managers holding ZEPP, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 28 managers held 2.26M shares, worth $12M. During the quarter 8 opened a position, 12 closed one, 9 added and 5 trimmed.
The largest holders, Q2 2026
- Morgan StanleyIn the quarter+4.8%
- FilIn the quarter+0.1%
- Price T Rowe AssociatesIn the quarter
- Yiheng Capital ManagementIn the quarter+282%
- Allspring Global Investments HoldingsIn the quarter
- CitigroupIn the quarter
- Mirae Asset Global Etfs HoldingsIn the quarter-2.8%
- Marshall WaceIn the quarter
- Susquehanna International GroupIn the quarter
- UBS GroupIn the quarter-34%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Morgan Stanley | 741.8K | +4.8% | $3.9M |
| Fil | 718.2K | +0.1% | $3.7M |
| Price T Rowe Associates | 311.9K | $1.6M | |
| Yiheng Capital Management | 220.5K | +282% | $1.1M |
| Allspring Global Investments Holdings | 46.7K | $243.6K | |
| Citigroup | 40.0K | $208.4K | |
| Mirae Asset Global Etfs Holdings | 30.3K | -2.8% | $157.9K |
| Marshall Wace | 26.2K | $136.3K | |
| Susquehanna International Group | 23.9K | $124.4K | |
| UBS Group | 22.6K | -34% | $117.6K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Zepp Health's filings show?
Who buys and sells is one part of Zepp Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ZEPP's insiders bought or sold?
From Jun 29, 2026 to Sep 25, 2026 Zepp Health's insiders bought 0 and sold $87.5K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.